Derek Bagley, Author at Endocrine News

Collaboration Is Paramount: Ashley B. Grossman’s Transatlantic Legacy

Honored by both the Endocrine Society and the European Society of Endocrinology with the 2025 Transatlantic Alliance Award, Ashley B. Grossman, F.Med.Sci, has made significant contributions to endocrine research on both sides of the Atlantic. Endocrine News speaks with Grossman about what this award means to him, what drew him to endocrinology in the first...

Masthead Maestro: Q&A with Manuel Tena-Sempere, MD, PhD, the Next Editor-in-Chief of Endocrinology

Starting in January 2026, the masthead of the Endocrine Society’s flagship basic science journal Endocrinology will have a new name at the top: Manuel Tena-Sempere, MD, PhD. He speaks to Endocrine News about his new role, how the journal has impacted his own research career, and how he plans to make the journal more appealing...

From Growth to Cancer: The Double Life of Growth Hormone

A growing body of research reveals that growth hormone (GH), long known for its role in growth and development, may have a darker side — one that could be manipulated for therapeutic benefit in cancer. A comprehensive review published in Endocrine Reviews spotlights the role of GH in cancer development and progression and evaluates the...

New Guidelines Reexamine Hirsutism

A new set of clinical guidelines published in the Journal of Clinical Endocrinology & Metabolism is reshaping how physicians diagnose and treat hirsutism, a condition that causes excessive male-pattern hair growth in women. Affecting roughly 10% of women worldwide, hirsutism has long been viewed through a primarily cosmetic lens. But the updated recommendations emphasize a...

Should SGLT2 Inhibitors Be Stopped Before Emergency Surgery?

A new study entitled “Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users” published in JAMA Surgery calls into question the current guidelines advising doctors to pause a widely used class of diabetes drugs—sodium-glucose cotransporter 2 inhibitors (SGLT2i) — before surgery. The findings suggest the risk of developing postoperative euglycemic ketoacidosis (eKA), a serious and potentially...

Pharma Fridays – June 27, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Results from AMGEN’S Phase 2 Obesity Study OF Monthly MariTide Presented at The American Diabetes Association 85th Scientific Sessions MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau,...

Obesity

New Study Questions BMI Accuracy in Childhood Obesity Screening

A new study from the Avon Longitudinal Study of Parents and Children (ALSPAC) is challenging long-held assumptions about how we measure overweight and obesity in children. According to findings published in Obesity and Endocrinology in January 2025, body mass index (BMI) — the most commonly used tool for assessing weight status — may dramatically overestimate...

Saliva Test One Step Closer to Replacing Blood Work for Adrenal Disorder Diagnosis

Salivary cortisol and cortisone can be valuable tools in diagnosing adrenal insufficiency (AI), offering non-invasive options for screening and potentially avoiding the need for ACTH stimulation tests in some cases, states a recent study in The Journal of Clinical Endocrinology and Metabolism. Adrenal insufficiency (AI), such as in cases of Addison’s disease and Congenital Adrenal Hyperplasia,...